2020
DOI: 10.1177/2048872620974605
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac complications in patients hospitalised with COVID-19

Abstract: Aims: To determine the frequency and pattern of cardiac complications in patients hospitalised with coronavirus disease (COVID-19). Methods and results: CAPACITY-COVID is an international patient registry established to determine the role of cardiovascular disease in the COVID-19 pandemic. In this registry, data generated during routine clinical practice are collected in a standardised manner for patients with a (highly suspected) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requiring… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
132
0
11

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
2
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 129 publications
(149 citation statements)
references
References 22 publications
6
132
0
11
Order By: Relevance
“…Outcome definitions of in-hospital complications have been reported previously. 19 For STROCORONA, patient files of all eligible cases were systematically screened and scored by neurologists or other physicians with experience in stroke research to identify acute ischemic stroke during hospitalisation. In addition, data on prior neurovascular diseases, including transient ischemic attack (TIA), ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, or vascular dementia, were collected.…”
Section: Study Population and Data Collectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Outcome definitions of in-hospital complications have been reported previously. 19 For STROCORONA, patient files of all eligible cases were systematically screened and scored by neurologists or other physicians with experience in stroke research to identify acute ischemic stroke during hospitalisation. In addition, data on prior neurovascular diseases, including transient ischemic attack (TIA), ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, or vascular dementia, were collected.…”
Section: Study Population and Data Collectionmentioning
confidence: 99%
“…Coronavirus disease 2019 (COVID- 19) is a pandemic that has affected millions of people worldwide. Although respiratory symptoms are the predominant feature of the disease, the clinical course of COVID-19 may be complicated by venous and arterial thromboembolic events.…”
Section: Introductionmentioning
confidence: 99%
“…Studies show that a significant number of patients who develop severe symptoms of COVID-19 have underlying comorbidities, of which cardiovascular disease (CVD) is reported in 10 -30% of inpatients in Western-European and American cohorts. [8][9][10][11] Patients with pre-existing cardiac disease have consistently been reported to be at increased risk of an unfavorable outcome both among the general population and those requiring hospitalization when compared to patient without these conditions. 8,12 In one of the largest cohort studies of hospitalized patients thus far (n=20,133), chronic cardiac disease was significantly associated with mortality (adjusted HR 1.16; 95% confidence interval (CI) 1.08 -1.24).…”
Section: Introductionmentioning
confidence: 99%
“…As this editorial is being written (on Christmas Eve, 2020), cases and deaths continue to rise globally. Almost a year after the start of the pandemic, many characteristics of the virus and its complications, including associated cardiovascular (CV) disease, have not been fully elucidated [2] . The medical community has been confronted by an unprecedented challenge and has had to use every available tool to develop and update knowledge (almost daily) to improve patient care.…”
mentioning
confidence: 99%
“…Research conducted regarding the CV manifestations of COVID-19 was not immune to these problems. Initially considered a rare complication, and later seen as a main focus of attention, studies are continuously demonstrating the true magnitude of the CV impact and associated long-term effects of the virus [2] . Multiple pathophysiological mechanisms, biomarkers, diagnostic algorithms, and therapeutic targets have been proposed throughout these past months without the development of an absolute consensus on how to approach the consequences of COVID-19 on the CV system [ 8 , 9 ].…”
mentioning
confidence: 99%